Ocular Manifestations in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

被引:12
|
作者
Liisborg, Charlotte [1 ,2 ]
Hasselbalch, Hans Carl [2 ,3 ]
Sorensen, Torben Lykke [1 ,2 ]
机构
[1] Zealand Univ Hosp, Dept Ophthalmol, Vestermarksvej 23, Roskilde 4000, Denmark
[2] Univ Copenhagen, Fac Hlth & Med Sci, Blegdamsvej 3B, Copenhagen 2200, Denmark
[3] Zealand Univ Hosp, Dept Haematol, Vestermarksvej 15-17, Roskilde 4000, Denmark
关键词
ocular manifestations; ocular complications; philadelphia-negative myeloproliferative neoplasms; RETINAL BLOOD-FLOW; LOW-DOSE ASPIRIN; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; EXTRAMEDULLARY HEMATOPOIESIS; INITIAL MANIFESTATION; OPHTHALMIC MANIFESTATIONS; CHOROIDAL THICKNESS; ARTERIAL-OCCLUSION; VENOUS THROMBOSIS;
D O I
10.3390/cancers12030573
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The major complications of Philadelphia-negative (Ph-Negative) myeloproliferative neoplasms (MPNs) are thrombosis, haemorrhage and leukemic transformation. As systemic and haematological diseases, MPNs have the potential to affect many tissues and organs. Some complications lead to the diagnosis of MPNs, but other signs and symptoms are often misdiagnosed or neglected as a sign of MPN disease. Therefore, we reviewed the current literature to investigate and delineate the clinical manifestations seen in the eyes of Ph-negative MPN patients. We found that ocular manifestations are common among patients with MPNs. The most frequently described manifestations are due to the consequences of haematological abnormalities causing microvascular disturbances and hyperviscosity. More serious and vision-threatening complications as thrombotic events in the eyes have been repeatedly reported as well. These ocular symptoms may precede more serious extraocular complications. Accordingly, combined ophthalmological and haematological management have the potential to discover these diseases earlier and prevent morbidity and mortality in these patients. Furthermore, routine ophthalmological screening of all newly diagnosed MPN patients may be a preventive approach for early diagnosis and timely treatment of the ocular manifestations.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Splenic Infarction in Patients with Philadelphia-negative Myeloproliferative Neoplasms
    Lee, Myung-Won
    Yeon, Sang-Hoon
    Ryu, Hyewon
    Song, Ik-Chan
    Lee, Hyo-Jin
    Yun, Hwan-Jung
    Kim, Seon Young
    Shin, Kyung Sook
    Jo, Deog-Yeon
    INTERNAL MEDICINE, 2022, 61 (23) : 3483 - 3490
  • [2] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Krecak, Ivan
    Peran, Nena
    Lapic, Ivana
    Gveric-Krecak, Velka
    Krecak, Filip
    Roncevic, Pavle
    Durakovic, Nadira
    WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (1-2) : 62 - 64
  • [3] Smoking and philadelphia-negative chronic myeloproliferative neoplasms
    Sorensen, Anders Lindholm
    Hasselbalch, Hans Carl
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 97 (01) : 63 - 69
  • [4] Serum procalcitonin in Philadelphia-negative myeloproliferative neoplasms
    Ivan Krečak
    Nena Peran
    Ivana Lapić
    Velka Gverić-Krečak
    Filip Krečak
    Pavle Rončević
    Nadira Duraković
    Wiener klinische Wochenschrift, 2021, 133 : 62 - 64
  • [5] Inflammatory picture of Philadelphia-negative myeloproliferative neoplasms
    Barbosa Pagnano, Katia Borgia
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2018, 40 (02) : 101 - 102
  • [6] IMPORTANCE OF COAGULATION ASSESSMENT IN PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS PATIENTS
    Kabat, M. Gasior
    Pollmar, M. I. Rivas
    Roman, M. T. Alvarez
    Manzano, E. Monzon
    Butta, P. Acuna
    Salgado, E. G. Arias
    Salces, M. Martin
    Giulinai, M. Facal
    Marugan, P. Gonzalez
    De Bustamante, J. Martin
    Serrano, L. Gomez
    Barcenilla, S. Garcia
    Castro, C. Ramos
    Coll, N. Butta
    Yuste, V. Jimenez
    HAEMOPHILIA, 2023, 29 : 166 - 166
  • [7] Molecular characterization of Philadelphia-negative myeloproliferative neoplasms
    Brisci, Angela
    Pietra, Daniela
    Foglieni, Barbara
    Boggi, Sabrina
    Rumi, Elisa
    Passamonti, Francesco
    Ferrari, Maurizio
    Cremonesi, Laura
    BIOCHIMICA CLINICA, 2010, 34 (02) : 110 - 114
  • [8] Applications of Artificial Intelligence in Philadelphia-Negative Myeloproliferative Neoplasms
    Elsayed, Basel
    Elshoeibi, Amgad M.
    Elhadary, Mohamed
    Ferih, Khaled
    Elsabagh, Ahmed Adel
    Rahhal, Alaa
    Abu-Tineh, Mohammad
    Afana, Mohammad S.
    Abdulgayoom, Mohammed
    Yassin, Mohamed
    DIAGNOSTICS, 2023, 13 (06)
  • [9] Philadelphia-negative myeloproliferative neoplasms among Kuwaiti Nationals
    Alshemmari, Salem
    Almazyad, Mazyad
    Alwehaib, Aisha
    Ameen, Reem
    CANCER MEDICINE, 2021, 10 (01): : 365 - 371
  • [10] Highly Deregulated Fibulins in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Skov, Vibe
    Thomassen, Mads
    Kjaer, Lasse
    Larsen, Thomas Stauffer
    Kruse, Torben A.
    Larsen, Thomas Stauffer
    BLOOD, 2019, 134